Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
200 mg | Warenkorb auf Verfügbarkeit prüfen | € 407,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
pyrazinamide
manufacturer/tradename
USP
mp
189-191 °C (lit.)
application(s)
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
NC(=O)c1cnccn1
InChI
1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)
InChI key
IPEHBUMCGVEMRF-UHFFFAOYSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Pyrazinamide Tablets
- Pyrazinamide Compounded Oral Suspension
- Rifampin, Isoniazid, and Pyrazinamide Tablets
- Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride Tablets
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description Pharmaceutical Secondary Standard; Certified Reference Material | description - | description British Pharmacopoeia (BP) Reference Standard |
| grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade - | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename - | manufacturer/tradename BP |
| application(s) pharmaceutical | application(s) pharmaceutical | application(s) - | application(s) pharmaceutical |
| format neat | format neat | format - | format neat |
| mp 189-191 °C (lit.) | mp 189-191 °C (lit.) | mp - | mp 189-191 °C (lit.) |
| API family pyrazinamide | API family pyrazinamide | API family - | API family pyrazinamide |
Still not finding the right product?
Explore all of our products under Pyrazinamid
Lagerklasse
11 - Combustible Solids
WGK
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

